Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Cytokinetics announced inducement-based grants of stock options and restricted stock units to 33 newly hired employees as an incentive for employment. The awards vest over 3 to 4 years and comply with Nasdaq Listing Rule 5635(c)(4). Cytokinetics is a biopharmaceutical company developing cardiac muscle disease treatments including MYQORZO® (aficamte…